2nd China Pharma IP Summit

Pharmaceutical & Life Sciences Litigation chair Steve Auten will participate in the panel discussion “The US Supreme Court Ruling on Amgen vs. Sandoz Case and What Developers Need To Know?” at the 2nd China Pharma IP Summit on Dec. 8 in Shanghai. The panel will include a detailed discussion of the patent dance and notice of commercial marketing as required for biosimilar applicants.

More information and full agenda located here.